Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04309409 |
|---|---|
| Brief Title: | Adjuvant Nivolumab Treatment in Stage II (IIA, IIB, IIC) High-risk Melanoma (NivoMela) |
| First Submitted : | March 12, 2020 |
| First Submitted that Met QC Criteria : | March 12, 2020 |
| First Posted : | March 16, 2020 |
| Last Update Submitted that Met QC Criteria : | November 1, 2022 |
| Last Update Posted : | November 2, 2022 |